← Open Payments lookup

MAY DEE GEMILO: Open Payments

NPI 1639645674 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,351 in 79 payments from 13 companies in 2025. Trend: 2023 $352 · 2024 $2,060 · 2025 $1,351

Food & beverage: $1,351
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$194
ABBVIE INC.12$178
Vanda Pharmaceuticals Inc.9$157
Teva Pharmaceuticals USA, Inc.11$156
Supernus Pharmaceuticals, Inc.9$140
Alkermes, Inc.5$122
E.R. Squibb & Sons, L.L.C.4$93
Otsuka America Pharmaceutical, Inc.3$72
Axsome Therapeutics, Inc.4$71
Janssen Pharmaceuticals, Inc3$59

Products named: CAPLYTA, VRAYLAR, FANAPT, Qelbree, AUSTEDO XR, ARISTADA, COBENFY, REXULTI.

Industry payments across WA — which companies pay providers there.